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ARTICLE
Oxidation of SQSTM1/p62 mediates the link
between redox state and protein homeostasis
Bernadette Carroll1, Elsje G. Otten1, Diego Manni1, Rhoda Stefanatos1, Fiona M. Menzies2, Graham R. Smith 1,3,
Diana Jurk 1, Niall Kenneth1, Simon Wilkinson 4, Joao F. Passos1, Johannes Attems5, Elizabeth A. Veal1,
Elisa Teyssou6, Danielle Seilhean6,7, Stéphanie Millecamps6, Eeva-Liisa Eskelinen8, Agnieszka K. Bronowska9,
David C. Rubinsztein2,10, Alberto Sanz 1 & Viktor I. Korolchuk1
Cellular homoeostatic pathways such as macroautophagy (hereinafter autophagy) are
regulated by basic mechanisms that are conserved throughout the eukaryotic kingdom.
However, it remains poorly understood how these mechanisms further evolved in higher
organisms. Here we describe a modiﬁcation in the autophagy pathway in vertebrates,
which promotes its activity in response to oxidative stress. We have identiﬁed two
oxidation-sensitive cysteine residues in a prototypic autophagy receptor SQSTM1/p62, which
allow activation of pro-survival autophagy in stress conditions. The Drosophila p62
homologue, Ref(2)P, lacks these oxidation-sensitive cysteine residues and their introduction
into the protein increases protein turnover and stress resistance of ﬂies, whereas
perturbation of p62 oxidation in humans may result in age-related pathology. We propose
that the redox-sensitivity of p62 may have evolved in vertebrates as a mechanism that allows
activation of autophagy in response to oxidative stress to maintain cellular homoeostasis and
increase cell survival.
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Pathological processes such as ageing and age-relateddiseases are commonly associated with oxidative DNAand protein damage, with cells employing multiple
homoeostatic mechanisms to promote survival in these
conditions1,2. Autophagy has an important role in maintaining
a functional proteome by degrading damaged proteins and
organelles that are potentially toxic3. Autophagy is also important
for cell survival in stress conditions4 and promotes longevity in a
diverse range of species from yeast to mammals5, however it
remains unknown whether the longer lifespan characteristic of
higher organisms requires evolutionary adaptations to the
autophagy machinery4,6–10.
Recruitment of substrates for degradation through the
autophagy pathway is mediated by a family of receptor
proteins11,12. SQSTM1/p62 is a prototypic autophagic receptor
molecule that links ubiquitylated substrates to the nascent
autophagic vesicles11,13. p62 contains extended disordered
regions and several structural domains including an N-terminal
PB1 (Phox and Bem1p) domain, which is involved in non-
covalent oligomerisation of the molecule14–19. The PB1 domain is
essential for the formation of intracellular aggregates of p62 and
associated ubiquitylated proteins (e.g. in conditions of autophagy
deﬁciency). Oligomerisation and aggregation of p62 is also
important for autophagic degradation of the protein together with
associated substrates by mediating high-avidity binding to LC3-II
on nascent autophagic membranes and promoting the formation
of the autophagosome around the cargo16,17,20.
Age-related neurodegeneration in p62 knockout mice and the
identiﬁcation of sporadic mutations in p62 in patients suffering
from late-onset amyotrophic lateral sclerosis (ALS) suggest that
p62 is important for neuronal survival21,22. Several of the p62
mutations identiﬁed in ALS are located within disordered regions
of the molecule, and the mechanisms by which they may lead to
the disease remain unknown22–24.
Here we demonstrate that in vertebrates, p62 senses the
saturation of reactive oxygen species (ROS)-buffering systems,
and that this redox-sensitivity is important to increase autophagy,
and thus ensure the survival of cells under oxidative stress
conditions. Furthermore, our data suggest one of the mutations
causing ALS affects the redox-sensitivity of p62.
Results
Oxidation of p62 promotes its oligomerisation. Our
comparative analysis of mouse brain tissue detected an
accumulation of high molecular weight species of p62 in old
animals (Fig. 1a). These were sensitive to reducing agents
suggesting that they are mediated by oxidation and disulphide
bond formation involving p62 molecules and therefore designated
disulphide-linked conjugates (DLC). Oxidation of p62 was con-
sistent with increased hyperoxidised peroxiredoxins (PRDX-SO3)
in old tissues, signifying redox imbalance25 (Fig. 1a). Despite no
observable differences in the levels of p62 mRNA or protein in
brain tissue (Fig. 1a; Supplementary Fig. 1a), intracellular
aggregates of p62 were signiﬁcantly increased in neurons of old
animals, suggesting that DLC of p62 may contribute to its
aggregation (Fig. 1b).
To investigate the mechanism of p62 DLC formation, we
exposed cultured cells to a range of treatments and analysed by
western blotting in non-reducing and reducing conditions (Fig. 1c;
Supplementary Fig. 1b). Treatments with autophagy inhibitors
baﬁlomycin A1 and chloroquine14,26,27 promoted the
accumulation of p62 without signiﬁcant formation of DLC
(Fig. 1c). Likewise, the ribosomal poison puromycin and
apoptosis inducing agent staurosporine, which are both known
to cause oligomerisation and aggregation of p6213,28 did not
induce DLC formation (Supplementary Fig. 1b). In contrast,
oxidative stress induced by H2O2 or PR-619 (a redox cycler
known to produce hydrogen peroxide in aqueous solutions, cause
oxidation of cysteine residues and non-speciﬁcally inhibit activity
of deubiquitylating enzymes (DUBs)29,30) resulted in the
formation of p62 conjugates similar to those observed in mouse
tissue (cf. Fig. 1a, c). Treatment with PR-619 produced more p62
DLC compared to H2O2, with the majority of the protein
migrating as high molecular weight complexes including a
fraction retained in the stacking gel (Fig. 1c). This correlated
with signiﬁcantly higher levels of intracellular ROS compared to
H2O2 treatment indicating that PR-619 is a stronger pro-oxidant
(Supplementary Fig. 1c). The ability of PR-619 to induce both
increases in intracellular ROS and p62 DLC was suppressed by
antioxidants such as N-acetylcysteine (NAC, Supplementary
Fig. 1c, d). In contrast, another DUB inhibitor N-ethylmaleimide
did not induce the formation of p62 DLC (Supplementary
Fig. 1e). Treatment of puriﬁed recombinant human p62 expressed
in E. coli with H2O2 or PR-619 in vitro induced the formation of
DLC conﬁrming the direct pro-oxidant activity of PR-619
(Supplementary Fig. 1f), and importantly, demonstrating that
p62 alone is sufﬁcient for the formation of DLC and does not
require inhibition of DUBs.
In conditions of p62 DLC formation, we also observed an
increase in intracellular p62 aggregates compared with untreated
controls (Fig. 1d). Further support for the aggregation-promoting
role of DLC came from ultracentrifugation analysis, which
showed that induction of DLC shifts p62 into an insoluble
fraction (Supplementary Fig. 2a). Therefore, in addition to
non-covalent interactions such as PB1 domain-dependent
oligomerisation, aggregation of p62 can also be facilitated by
DLC formation.
Analysis of the kinetics of p62 oxidation in tissue culture with
H2O2 demonstrated a rapid concentration-dependent response
(Supplementary Fig. 3a). Formation of p62 DLC appeared to be
reversible at lower concentrations of H2O2 with a more sustained
response at higher doses. To test whether DLC can be reduced by
thioredoxin family proteins we examined the effect of thioredoxin
reductase inhibitors curcumin31 or auranoﬁn32 on this process.
Both treatments induced sustained DLC formation consistent
with thioredoxin activity being required to reduce DLC
(Supplementary Fig. 3b). These observations suggest that p62
DLC are stabilised when protein oxidation is increased beyond
the capacity of thioredoxin to reduce oxidised oligomers.
Treatment with PR-619 resulted in a gradual increase in p62
DLC formation with increasing length of cell exposure, suggesting
that it resulted in sustained oxidative stress (Supplementary
Fig. 3c). Therefore, H2O2 and PR-619 were subsequently used in
parallel as tools to stimulate DLC formation.
Cysteine residues 105 and 113 mediate p62 DLC formation. To
identify which cysteine (Cys) residues were involved in the
formation of p62 DLC, four fragments of p62 were analysed
(Supplementary Fig. 4a). The N-terminal region (amino acids
1–122), containing the PB1 domain and the ﬂanking unstructured
regions, was found to be sufﬁcient to form DLC in response to
oxidative stress, whereas the rest of the molecule did not appear
to participate in this process (Supplementary Fig. 4b). The 1–122
fragment contains ﬁve Cys residues with C105 and C113 being
the most conserved among the 14 analysed vertebrate species
(Fig. 2a; Supplementary Fig. 5a). The two Cys residues with the
highest degree of conservation lie in a disordered region
encompassing amino acids 102–121 (Supplementary Fig. 5a).
Interestingly, while no single cysteine (C) to alanine (A)
substitution completely prevented DLC formation, single
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mutagenesis of either C105 or C113 resulted in a partial
impairment of this process (Supplementary Fig. 5b). Moreover,
double substitution of C105 and C113 signiﬁcantly reduced the
levels of p62 oxidation detected after H2O2 or PR-619 treatments
in cell culture and in vitro (Fig. 2b; Supplementary Fig. 5c, d).
Substitutions of other Cys residues did not further ablate DLC
formation (Supplementary Fig. 6), suggesting that C105 and C113
residues are required for efﬁcient ROS sensing. The K7A,D69A
double-mutation, which disrupts the PB1 domain-dependent
oligomerisation of p6214, did not suppress DLC formation
(Supplementary Fig. 5c) suggesting that the formation of
disulphide bonds does not require prior non-covalent interactions
via the PB1 domain.
Notably, the C105A,C113A mutant formed signiﬁcantly fewer
intracellular aggregates following exposure to H2O2 or PR-619,
consistent with DLC formation promoting the aggregation of p62
(Fig. 2c, d). Furthermore, ultracentrifugation experiments
conﬁrmed that wild type, but to a much lesser extent C105A,
C113A-mutant p62, was redistributed to the insoluble fraction
upon exposure to oxidants (Supplementary Fig. 7a, b). In
agreement with the requirement of p62 for the formation of
ubiquitylated protein aggregates33,34, p62 aggregates were
ubiquitylated and as such cells expressing C105A,C113A p62
also displayed signiﬁcantly fewer intracellular ubiquitin-positive
aggregates (Fig. 2c, d).
As both PB1 domain-dependent and disulphide bond-
mediated mechanisms appear to contribute to p62 aggregation,
we investigated the relationship between the two processes.
Although disruption of PB1 domain-mediated interactions (K7A,
D69A mutation) did not preclude the formation of DLC in
response to oxidation (Supplementary Fig. 5c), it did suppress the
formation of intracellular p62 aggregates in the same conditions
(Supplementary Fig. 8a). Thus, although oxidation of p62 can
promote p62 oligomerisation, the PB1 domain appears to be
required for sequestration of these oligomers into microscopically
observable aggregates. Although the PB1 domain is also essential
for the formation of p62 aggregates in conditions of autophagy
inhibition (Supplementary Fig. 8a), C105/C113 residues were
dispensable for this process (Supplementary Fig. 8b, c) suggesting
that redox sensing by p62 is important for its aggregation
speciﬁcally in response to oxidative stress.
Oxidation of p62 activates pro-survival autophagy.
Cycloheximide chase experiments demonstrated slower
degradation of the C105A,C113A mutant compared to wild-type
p62 in oxidative stress conditions, which was further conﬁrmed
using the Click-iT pulse-chase technique (Fig. 3a; Supplementary
Fig. 9a, b). The difference between the C105A,C113A-mutant
and wild-type p62 was cancelled out by baﬁlomycin A1 or
b
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Fig. 1 p62 forms oligomers and aggregates in response to oxidation. a Mouse brain tissue, young (3 months) and old (24 months) analysed by
immunoblotting for p62, PRDX-SO3 and actin as a loading control in reducing (2.5% β-ME) and non-reducing conditions. DLC disulphide-linked conjugates.
Arrows indicate the positions of monomeric and oligomeric p62. b Representative images and quantiﬁcation of p62 aggregates in old mouse Purkinje cells
in the cerebellum. Green arrows and red arrowheads indicate Purkinje cells positive and negative for p62 aggregates, respectively. c Effect of autophagy
inhibition (baﬁlomycin A1 (Baf, 400 nM, 4 h) and chloroquine (CQ, 50 μM, 4 h)) and oxidative stress (H2O2 (3 mM, 10min) and PR-619 (5 μM, 30min))
on p62 DLC (c) and p62 aggregation (d) in HeLa cells. d Anti-p62 staining analysed by confocal microscopy. Error bars represent s.e.m., n= 3, *P< 0.05,
**P< 0.01, ***P< 0.005 (unpaired t-tests). Asterisk indicates a non-speciﬁc band. Scale bar: 20 µm
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chloroquine, suggesting that oxidation of p62 promotes its
degradation by autophagy (Fig. 3b; Supplementary Fig. 9c).
Indeed, wild type but not the C105A,C113A mutant of p62
appeared to stimulate autophagy as indicated by increased levels
of LC3-II and reduced levels of ubiquitylated proteins and p62
itself (Fig. 3c, d). This effect on autophagy markers was
particularly pronounced upon exposure to H2O2 or PR-619,
suggesting the importance of p62 for oxidative stress-induced
autophagy (Fig. 3c, d; Supplementary Fig. 9d). The failure of
p62-null cells or cells expressing oxidation-insensitive p62 mutant
to induce autophagy was also evident from the signiﬁcantly
reduced numbers of autophagosomes as assessed by immuno-
ﬂuorescence (Fig. 3e, f) and electron microscopy (Fig. 3g, h).
Oligomerisation of p62 via non-covalent PB1 domain-dependent
interactions has previously been suggested to promote the for-
mation of the autophagosome around cargo16,17. Cells expressing
the PB1 domain mutant (K7A,D69A) of p62 displayed a similar
deﬁciency in autophagy to that observed in C105A,C113A-
mutant cells (Fig. 3c–h; Supplementary Fig. 9d), suggesting that
common mechanisms underlie the role of non-covalent and
disulphide bond-mediated p62 oligomerisation in promoting
autophagosome biogenesis.
As degradation of misfolded proteins by autophagy has been
shown to be important for cell survival35,36, we investigated
whether oxidation of p62 promotes cell viability in oxidative
stress conditions. Strikingly, compared to cells expressing
wild-type FLAG-p62, cells lacking p62 or expressing the
C105A,C113A mutant were more susceptible to cell death
following oxidative stress (Fig. 3i, j; Supplementary Fig. 9e)37,38.
Likewise, the PB1 domain mutant failed to maintain cell viability,
in agreement with a common underlying mechanism of p62
oligomerisation as a pre-requisite for cell survival (Fig. 3i, j). The
differences in cell survival cannot be explained by the effect of p62
on oxidative stress response via Nfr2 (Supplementary Fig. 10a–d)39.
Instead, baﬁlomycin A1 or chloroquine treatment cancelled out the
difference in cell survival between the cell lines, conﬁrming
autophagy as a mechanism of resistance (Fig. 3j). On the basis of
this data, we propose that p62 oxidation and oligomerisation
promotes autophagosome biogenesis and degradation of ubiquity-
lated autophagy cargo and is therefore important for maintaining
cell viability in stress conditions.
Oxidation of p62 confers stress resistance in vivo. Interestingly,
although mouse and human p62 is oxidised (Fig. 1), the
oxidation-sensitive Cys residues are not conserved in p62
homologues in invertebrates including ﬂies and worms
(Supplementary Fig. 5a). Indeed, the Drosophila homologue,
Ref(2)P does not form DLC in old animals or in response to
H2O2 (Fig. 4a; Supplementary Fig. 11a). This raises the possibility
that this lack of redox-sensitivity is responsible for the observed
accumulation of Ref(2)P in aged ﬂies (cf. Figs. 1a and 4a). To test
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whether acquisition of ROS sensing by p62 might confer an
advantage by promoting autophagy and stress resistance, an
eighteen amino acid fragment of human p62 containing C105
and C113 was used to replace the corresponding region in the ﬂy
Ref(2)P gene using CRISPR/Cas9 technology (Fig. 4b). The
resulting protein was shown to be oxidised in response to H2O2
and therefore designated Ref(2)POX (Fig. 4b; Supplementary
Fig. 11a). Compared to wild type, Ref(2)POX ﬂies displayed
increased autophagy ﬂux, as indicated by the increased levels of
LC3-II homologue Atg8-II in the presence of the lysosomal
a b
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inhibitor chloroquine (Supplementary Fig. 11b). No differences in
Atg8-II levels were detected in the absence of lysosomal inhibitor,
likely to be due to its increased turnover together with ubiqui-
tylated proteins and Ref(2)POX in aged Ref(2)POX animals
(Supplementary Fig. 11c). Strikingly, in acute stress conditions,
induced by paraquat or thermal stress40,41, the survival of Ref(2)
POX ﬂies was extended, which also correlated with enhanced
turnover of ubiquitylated proteins and Ref(2)POX itself (Fig. 4c, d;
Supplementary Figs. 11d, 12a, b).
To investigate whether perturbation of p62 oxidation could
underlie pathology in humans, we searched for known mutations
in the highly ﬂexible loop of p62 containing the C105/C113
residues. A K102E mutation (Supplementary Fig. 5a) has previously
been identiﬁed as causative in sporadic ALS (SALS)23,24. On the
basis of the above data, we generated a hypothetical in silico model
of disulphide bond-mediated p62 oligomerisation, which predicted
that K102 may be involved in the salt-bridge formation with E19
within the PB1 domain (Supplementary Fig. 13a). This salt bridge
could stabilise the protein, and also affect the conformation and
orientation of the near cysteine C105, enabling formation of the
disulphide bond between C105 and C113 from another
p62 subunit. K102E mutation would disrupt this stabilising
interaction and also perturb oxidation of the redox-sensitive
Cys105 residue through a large conformational change of the loop,
making it inaccessible for the formation of further disulphide bonds
(Supplementary Fig. 13a). Indeed, we found that the K102E
mutation (but not a number of unrelated mutations within
this region) impaired the ability of p62 to form DLC in response
to oxidative stress (Fig. 4e; Supplementary Fig. 13b), as well as
its ability to induce autophagy, thus suggesting a pathological
mechanism for this mutation in SALS (Supplementary Fig. 13c, d).
Determining the nature of p62 and DLC in ALS patients
harbouring the K102E mutation will be an important future step
to validate this model.
Discussion
The formation of p62 oligomers in response to oxidative stressors,
such as H2O242, cigarette smoke43 and UV-irradiation44 has been
previously reported. However, the high molecular weight species
of p62 observed were resistant to reducing agents suggesting a
separate formation mechanism to that described here. The
Cys105/113 residues required for DLC formation, together with
Lys102 (which is mutated in SALS) locate to a previously
described charged bridge, which was suggested to align in the
antiparallel orientation and promote oligomerisation of p62 via
non-covalent PB1 domain-mediated interactions45. Interestingly,
although the formation of intermolecular disulphide bonds
between oxidation-sensitive Cys residues in this model is possible,
the resulting DLC will be limited to p62 dimers that are not
observed in our experiments. Instead, we propose a putative
model of DLC formation involving a parallel orientation of p62
molecules, which could also explain the pathological mechanism
of the K102E mutation (Supplementary Fig. 13a). Although this
model requires testing in future structural studies our mutational
analyses suggest that the two processes of PB1 domain- and
DLC-mediated oligomerisation can act relatively independently,
however both can contribute to the formation of p62 aggregates.
Importantly, DLC formation appears to initiate or facilitate p62
oligomerisation in conditions of oxidative stress and promote the
formation of microscopically observable aggregates, the
latter process also requiring the function of its PB1 domain.
Importantly, cells carrying oxidation-insensitive or PB1 domain
defective mutants of p62 have similar functional phenotypes
(e.g. autophagy and cell survival defects) suggesting that,
regardless of the underlying molecular mechanism, oligomerisa-
tion of p62 is required for its cellular function.
Overall, our data implies that oxidation-dependent oligomer-
isation of p62 promotes autophagy and is a pro-survival
mechanism. In line with previous observations16,17,20,46, our
data show that autophagy receptors such as p62 act not only as
cargo carriers but also stimulate the process of autophagosome
formation. Furthermore, we propose that the sensitivity of p62 to
ROS-induced oxidation may have evolved in vertebrates as a
mechanism that allows more efﬁcient autophagy during oxidative
stress conditions, thereby maintaining cellular homoeostasis and
increasing cell survival (Fig. 4f). This mechanism may be parti-
cularly relevant to longer-lived species with a high metabolic rate
such as humans where it counteracts the effect of age-associated
oxidative stress and promotes survival of differentiated cells, in
particular neurons, for years and even decades of human lifespan.
Consistent with this view, our data suggest that perturbation
(e.g. by K102E mutation) of this redox sensitivity may occur in
age-related pathology in humans, although this remains to be
formally tested in vivo (Fig. 4f). In recent years, a growing
number of signalling proteins have been shown to be regulated by
ROS-induced changes in the redox state. Our data suggest that
such changes may also have an unanticipated role as a
mechanism of aggregation and degradation of proteins via the
autophagy pathway thus promoting cellular protein homoeostasis
in oxidative stress conditions. This has wider implications for the
myriad of important processes in which autophagy is implicated
including ageing, cancer cell survival and ischaemia/reperfusion
injury.
Methods
Cell lines. HeLa and HEK293E cells were obtained from ECACC (European
Collection of Cell Cultures). p62 knockout (p62−/−) and wild-type (p62+/+) mouse
embryonic ﬁbroblasts (MEFs) were kindly provided by Eiji Warabi of the Uni-
versity of Tsukuba. HEK293FT lentivirus packaging cells were from Invitrogen
(Paisley, UK). Cells were grown in DMEM (Dulbecco’s Modiﬁed Eagle’s Medium,
Sigma #D6546) supplemented with 10% heat-inactivated FCS (Foetal Calf Serum,
Biosera), 5% penicillin/streptomycin (Invitrogen) and 2mM L-glutamine (Sigma) in
a humidiﬁed atmosphere containing 5% CO2 at 37 °C. Cells were treated with
puromycin (Santa Cruz Biotechnology), staurosporine (Sigma), z-VAD (Sigma),
H2O2 (Sigma; the H2O2 stock was replaced every 2 weeks for the duration of the
project), PR-619 (LifeSensors), curcumin (Sigma), auranoﬁn (Sigma), N-
acetylcysteine (Sigma), baﬁlomycin A1 (Enzo Life Sciences), chloroquine (Sigma),
cycloheximide (Sigma) and retinoic acid (as an inhibitor of Nrf247) at different
Fig. 3 Oxidation-sensitive p62 is required for pro-survival autophagy. a p62−/− MEFs stably expressing FLAG-tagged wild type or C105A,C113A p62 were
treated with cycloheximide (CHX, 50 μg/ml) and H2O2 (1 mM), either in the absence (a) or presence (b) of baﬁlomycin A1 (Baf, 50 nM), lysed at the
indicated time post treatment, immunoblotted for p62 and quantiﬁed. c Cells described in a plus one stably expressing K7A,D69A PB1-domain mutant of
p62 were treated with H2O2 (1 mM, 5 h), lysed and immunoblotted for ubiquitin, LC3, p62 and actin (c) and quantiﬁed (d). e, f Stable p62 cell lines in
control conditions were ﬁxed and stained for p62 and LC3 (e) and the % cells with >20 autophagosomes was quantiﬁed (f). g, h Electron microscopy of
stable p62 cell lines. White arrows: autophagosomes; black arrows: autolysosomes; blue arrow: endosome. Scale bar: 500 nm (g). Autophagosomes were
quantiﬁed and graphs represent average number and % cells with three or more autophagosomes per ﬁeld of view (h). i, j Stable p62 cell lines were treated
as in c and % cell death was analysed by Ready Probes ﬂuorescent dyes (i). j Stable p62 cell lines were treated as indicated and % cell death was analysed
as in i. Error bars represent s.e.m., n= 3, *P< 0.05, **P< 0.01, ***P< 0.005 (unpaired t-tests). NS not signiﬁcant. Scale bar: 20 µm (IF) and 500 nm (TEM)
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concentration and time-points as indicated. Medium was switched to serum-free
DMEM for the duration of the treatments.
Transfection. HeLa cells and MEFs were seeded in either 6- or 12-well plates,
cultured for 24 (HeLa) or 48 (MEFs) hours and transfected with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions for 24 or 48 h prior
to lysis. Plasmids used in this study: pEGFP-p62, pEGFP-ΔUBAp62 and pDEST-
GST-p62 were kindly provided by Terje Johansen (University of Tromsø, Tromsø,
Norway)14, FLAG-p62 was kindly provided by Robert Layﬁeld (University of
Nottingham, Nottingham, UK)48, pEGFP-C2 (Clontech, #632481) and pLENTI6/
V5-DEST (Invitrogen, #V496-10).
Mutagenesis. Point mutagenesis of p62 was carried out using the QuikChange II
XL Site-Directed Mutagenesis Kit (Agilent Technologies) following the provided
protocol. Mutagenesis primers were designed using the QuikChange Primer Design
Program available online on the Agilent website (Supplementary Table 1). The
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pEGFP-p62, Flag-p62 and GST-p62 wild-type plasmids were used as a template.
PCR reactions were run on a Veriti 96-Well Thermal Cycler (Applied Biosystems).
Transformation of bacteria was then carried out using XL10-Gold ultracompetent
cells provided with the kit. Bacterial DNA was extracted using the QIAprep Spin
Miniprep Kit (Qiagen) and sent for sequencing (Genevision, Newcastle Upon
Tyne, UK).
Cloning. Deletions of p62 were produced through PCR, using the pEGFP-p62 wild
type as a template and speciﬁc primers generated by SnapGene software (GSL
Biotech) (Supplementary Table 1). The generated fragments were then ligated into
the pEGFP-C2 vector. Forward primers included a BglII restriction site. PCRs were
performed using Phusion High-Fidelity DNA polymerase (Thermo Scientiﬁc)
following the PCR standard protocol. PCR reactions were run on a Veriti 96-Well
Thermal Cycler (Applied Biosystems). p62 fragments were then digested with BglII
(sticky end, NEB) and run on agarose gel which was then puriﬁed. The pEGFP-C2
vector was digested with SmaI (blunt end, NEB) and run on agarose gel followed by
puriﬁcation with QIAquik GEL Extraction Kit (Qiagen). The pEGFP-C2 vector was
then digested with BglII, followed by gel puriﬁcation. After double digestion, the
vector was dephosphorylated by calf intestinal alkaline phosphatase (Fermentas).
The digested p62 fragments were ligated into the double-digested pEGFP-C2 vector
(sticky end/blunt-end ligation) using the T4 DNA Ligase (New England BioLabs).
Bacterial transformation was performed as described above using α-select GOLD
Efﬁciency chemically competent cells (Bioline). FLAG-p62 and FLAG-
C105AC113Ap62 for lentiviral expression were subcloned into the pLENTI6/
V5-DEST vector using EcoRI and XhoI (NEB) as described above.
qPCR of p62 and Nrf2 targets in MEFs and brain tissue. Total RNA was
extracted in triplicate from MEFs using Trizol (Thermo Scientiﬁc) and DNAase
treated. cDNA was synthesised using the High-Capacity cDNA reverse transcrip-
tion kit (Applied Biosystems) according to manufacturers instructions and
analysed using an Applied Biosystems Step One qPCR machine. Relative
expression of the target genes was normalised to actin levels. Data were extracted
and analysed using Applied Biosystems 7500 software version 2.0 and Prism
software. For each target mean fold change with standard error is presented.
RNA from mouse tissue was isolated from snap frozen tissues (n = 5 per group)
using RNeasy Mini Kit and QIAshredder (Qiagen) according to manufacturers
instructions. Total RNA was reverse-transcribed using Omniscript Reverse
Transcription Kit (Qiagen) according to manufacturers instructions. Samples were
analysed in triplicates using Power SyberR Green PCR Master Mix (Invitrogen) in
a C1000TM Thermal Cycler, CFX96TM Real‐Time System (Bio‐Rad) using
Bio‐Rad CXF Manager software. Expression was normalised to Pkg1. The
sequences of all the primers used are included in Supplementary Table 2.
GST-p62 fusion protein puriﬁcation. GST-p62 fusion protein was produced in
E. coli EXPRESS BL21 (DE3) Chemically Competent Cells (Lucigen) using the
pDEST-GST-p62 plasmid14. In brief, fusion protein expression was induced by
adding 0.5 mM ZnSO4 and 0.05 mM IPTG to induce expression for 3.5 h at 20 °C,
Bacterial pellets were lysed by sonication in 50 mM Tris, 150 mM NaCl buffer, pH
7.5 and GST-fusion protein puriﬁed using Glutathione-Sepharose 4B beads
(GE Healthcare). Puriﬁed GST-p62 fusion protein was then treated with H2O2 and
PR-619 as indicated and subjected to immunoblot analysis. Samples were sonicated
for 10 s prior to running on an 8% Tris-Glycine SDS-PAGE gel.
Lentiviral transduction. Stable expression of FLAG-p62, FLAG-C105A-C113A
p62, FLAG-K7A,D69Ap62 and FLAG-K102E p62 in p62−/− MEFs was achieved
through lentiviral transduction. Transgenes were cloned into the pLenti6/V5-DEST
expression vector containing the blasticidin resistance gene. HEK293FT cells were
seeded in antibiotic-free medium supplemented with 0.1 mM MEM non-essential
amino acids (Invitrogen) and then cotransfected with either empty or p62 lentiviral
expression vectors and 3rd generation packaging system plasmids (Invitrogen).
After 24 h, media was replaced with fresh media without antibiotics. 48 h after
transfection, viral transduction was performed by transferring media from
HEK293FT cells 70% conﬂuent p62−/− MEFs in the presence of 6 μg/ml Polybrene
(Sigma). Media containing virus was replaced after 24 h with fresh media
containing 8 μg/ml of blasticidin (Invitrogen) for selection of transduced cells.
Media was replaced every 2–3 days for 10–12 days by keeping the antibiotic
selection. Transduced MEFs were then maintained in lower levels of blasticidin
(4 μg/ml) until seeding for experimental purposes.
Immunoblot analysis. HeLa cells, MEFs or HEK293E were seeded in 6- or 12-well
plates 24 (HeLa) or 48 (MEFs) hours prior treatments. After treatments, cells were
washed in ice-cold 1× PBS then lysed in RIPA buffer (150 mM NaCl, 1% NP40,
0.5% NaDoC, 0.1% SDS, 50 mM Tris pH 7.4, supplemented with 1× Halt Protease
& Phosphatase inhibitor cocktail (Thermo Scientiﬁc) in ddH2O) plus 50 mM
N-ethylmaleimide, which interacts with reduced cysteines and prevents new
disulphide bond formation during lysis procedures and simultaneously inactivates
deubiquitylating enzymes. Cell lysates were then centrifuged at 4 °C at 13,000 rpm
for 10 min to remove insoluble cellular components. Protein concentration was
measured by Bradford assay using the DC Protein Assay (BioRad) and a FLUOstar
Omega plate reader (BMG Labtech). Samples were prepared by boiling in SDS-
Loading buffer (BioRad) at 100 °C for 5 min in the presence or absence of 2.5%
β-ME (β-mercaptoethanol, Sigma). An amount of 20–40 μg of proteins was run on
10–12% Tris-Glycine SDS-PAGE gels and transferred to Immobilon-P (Millipore)
PVDF membranes using a Trans-Blot SD Semi-Dry Transfer Cell (BioRad). Blots
were incubated with a blocking solution (PBS containing 5% fat-free dry milk, 0.1%
Tween-20) for 1 h. After washing with PBS, blots were incubated with primary
antibodies diluted in blocking solution at 4˚C overnight. Blots were then washed
three times, 5 min each: one time with PBS, once in PBS with 0.1% Tween-20 and
one more time in PBS. Then, blots were incubated with secondary HRP-conjugated
antibodies α-mouse or α-rabbit (Sigma, #A2554 and #A0545, 1:5000) or α-guinea
pig (Dako, #P0141, 1:1000) in blocking solution for 1 h at room temperature. Blots
were then washed three times as above. Blots were incubated for 5 min with the
Clarity Western ECL Substrate (BioRad) and signals were detected by chemilu-
minescence using a LAS-4000 CCD camera system (Fujiﬁlm). The following
primary antibodies were used: guinea pig α-p62 (Progen Biotechnik #GP62-C,
1:2000), mouse α-GFP (Santa Cruz Biotechnology #sc-9996, 1:1000), mouse α-
Ubiquitin (LifeSensors #VU101, 1:1000), rabbit α-PRDX349 (1:1000), α-PRDX-SO3
(Abcam #ab16830, 1:2000), mouse α-LC3 (Enzo Life Sciences #ALX-803-081-
C100, 1:1000), mouse α-FLAG (Sigma #F1804, 1:2000), rabbit α-FLAG (Sigma
#F7425, 1:2000), rabbit α-GAPDH (CST #5174, 1:10,000), rabbit α-actin (CST
#4970, 1:2000), rabbit α-Drosophila tubulin (Abcam #ab179513, 1:2000), Ref(2)P
(Abcam #ab178440, 1:1000) or (50, a kind gift from Ioannis Nezis, Warwick
University, 1:500), α-Drosophila Atg851 (a kind gift from Ivana Bjedov, UCL,
1:1000), rabbit α-Nrf2 (CST #12721, 1:500) and rabbit α-Histone H3 antibody
(CST #9715, 1:2000). Uncropped versions of western blots are presented in
Supplementary Fig. 14.
Ultracentrifugation. Lysates from HeLa cells and MEFs were ﬁrst centrifuged at
4 °C at 13,000 rpm for 10 min, and whole-cell samples were prepared by boiling in
SDS-Loading buffer (BioRad) at 100 °C for 5 min Supernatants where loaded into
1 ml polycarbonate cuvettes and centrifuged using an Optima TLX Ultracentrifuge
(Beckman Coulter, UK) at 100,000 rpm at 4 °C for 1 h. Soluble and insoluble
fraction samples were prepared by boiling supernatants and pellets in SDS-Loading
buffer (BioRad) at 100 °C for 5 min.
Cycloheximide degradation assays. p62−/−MEFs stably expressing FLAG-tagged
wild type or C105A,C113A p62 were seeded in 12-well plate until conﬂuent. Cells
were treated with cycloheximide (50 μg/ml) and either H2O2 (1 mM) or PR-619
(5 µM) for 0, 2, 4 and 6 h in serum-free media before being lysed and analysed by
immunoblot to monitor p62 degradation. Where co-treatment was carried out with
chloroquine (20 µM) or baﬁlomycin A1 (50 nM), cells were pretreated with these
drugs for one hour prior to addition of cycloheximide.
Fig. 4 Oxidation-sensitive p62 is important for the oxidative stress resistance of ﬂies and is perturbed in human age-related disease. a Whole-ﬂy lysates
were analysed in reducing (2.5% β-ME) and non-reducing conditions for p62 homologue, Ref(2)P. Asterisk indicates a non-speciﬁc band. b Diagram
representing the introduction of an 18 amino acid fragment of human p62 containing C105 and C113 to produce a ‘humanised’ Ref(2)P (Ref(2)Pox) in ﬂies
using CRISPR/Cas9. c Wild-type (WT) and Ref(2)Pox ﬂies were treated with paraquat (PQ, 20mM) for 12 h and whole-ﬂy lysates were analysed by
immunoblot for ubiquitin, Ref(2)P and tubulin and quantiﬁed. Error bars represent s.e.m., n= 3 (at least 10 ﬂies per group per replicate); *P< 0.05
(unpaired t-test). d Combined survival data (of three repeats) of wild-type versus Ref(2)Pox ﬂies in the presence of 20mM PQ. Survival was assessed
every 12 h. At least 60 ﬂies per group per replicate were used and log-rank statistics applied. e p62−/− MEFs stably expressing FLAG-tagged wild-type p62,
C105A,C113A p62 or ALS-associated mutation K102E p62 were treated with H2O2 (500 μM, 1 min) and PR-619 (20 μM, 10min), analysed for p62 DLC
formation in non-reducing conditions and quantiﬁed. Error bars represent s.e.m., n= 3; ***P< 0.005 (unpaired t-tests). f Diagram of the proposed role for
p62 oxidation in the aggregation and degradation of autophagy substrates. Formation of p62 DLC is triggered by oxidative stress, which promotes
degradation of p62 and bound substrates (e.g. ubiquitylated proteins) through autophagy. Mutations in p62 sequence (e.g. ALS-related K102E) can impair
the formation of DLC
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Click-iT AHA assay to measure rates protein degradation. Cells were seeded
into 100 mm dishes and grown until 70–80% conﬂuency. For labelling of newly
synthesised proteins, cells were washed once with PBS and incubated overnight
with 4 µM Click-iT AHA (L-azidohomoalanine) (ThermoFisher Scientiﬁc
#C10102) in DMEM without cysteine and methionine (ThermoFisher Scientiﬁc
#21013024). The following day, AHA was removed and cells were washed with PBS
and incubated in serum-free media containing 1mM H2O2 for the required chase
time (0–6 h). Cells were harvested into 400 µl p62 IP buffer (20 mM Tris pH 7.4,
150mM NaCl, 0.5% NP40, 2 mM MgCl2 and protease inhibitor cocktail (Roche))
and incubated on ice for 10 min. Lysates were centrifuged for 10 min at 15,000×g,
the supernatant was incubated with 20 µl of prewashed Ez-view M2 agarose beads
(Sigma) for 2 h at 4 °C with constant rotation. Beads were then washed three times
in p62 IP buffer. The AHA containing proteins were then labelled with biotin
(biotin alkyne, ThermoFisher Scientiﬁc B10185) on the beads via Click-iT Cell
Reaction Buffer Kit (ThermoFisher Scientiﬁc) and following the manufacturer’s
protocol. Finally beads were washed three times in p62 IP buffer before protein was
eluted by boiling in Laemmli sample buffer (BioRad). Eluted samples were run on
10% SDS-PAGE gels and transferred to low ﬂouresence PVDF membrane
(Millipore). Western blots were probed with streptavidin conjugated to IRdye800
(LiCor Biosciences) and visualised using an Odyssey Scanner (LiCor Biosciences).
Band intensity was quantiﬁed using Image Studio software (LiCor Biosciences).
Immunoﬂuorescence. HeLa cells and MEFs were seeded on coverslips in 12-well
plates. After treatments, cells were ﬁxed in 4% formaldehyde in PBS for 10 min at
room temperature. Cells were permeabilised with 0.5% Triton X-100 for 5 min at
room temperature (or in methanol at −20 °C for LC3 staining). Coverslips were
blocked for one hour in 5% normal goat or rabbit serum in PBS 0.05% Tween-20
(for LC3 staining, the Tween-20 was omitted from all steps). Cells were incubated
with primary antibodies overnight at 4 °C. Primary antibodies used in this study
include guinea pig α-p62 (Progen, 1:200), mouse α-p62 (BD Bioscience, 1:200),
goat α-Ubiquitin (Santa Cruz Biotechnology #sc-34870, 1:200), rabbit α-LC3 (CST
#3868, 1:200). Cells were washed three times and incubated with the appropriate
secondary antibodies for 1 h at room temperature (Life Technologies, 1:5000). Cells
were washed and nuclear DNA was stained by incubation with TO-PRO-3 iodide
(Life Technologies, 1:3000) for 10 min at room temperature. Coverslips were
mounted on slides with Prolong Gold Antifade (Life Technologies) and imaged
with an LSM 510 META Confocal Microscope (Zeiss) using a 63× Plan-Apo/1.4
NA Oil objective. Images were analysed using ImageJ software (NIH).
Electron microscopy. Cells were seeded 48 h prior to treatment and subjected to 2
h amino acid starvation. Cells were collected and ﬁxed overnight in 2%
glutaraldehyde in 0.1 M cacodylate buffer. After rinsing in buffer, the cells were
post-ﬁxed in 1% osmium tetroxide +1.5% potassium ferricyanide, rinsed in
deionised water then dehydrated through a graded series of acetone. Cells were
inﬁltrated with epoxy resin (TAAB medium) and polymerised at 60 °C for 36 h.
Ultrathin sections (70 nm) were picked up on copper grids and stained with uranyl
acetate and lead citrate before being viewed on a 100kV CM100 TEM (FEI). Images
of 20 cells per cell line were collected and quantiﬁed.
Cell death assay. Cells were seeded 48 h prior to treatments in 12-well plate. Cell
viability was assessed using Ready Probes (Life sciences) as per company
instructions. Cells were imaged on inverted DM IL LED Leica microscope
equipped with an Invenio 3SII digital camera (3.0 Mpix Colour CMOS; Indigo
Scientiﬁc). Images were analysed using ImageJ and the percentage of cell death was
quantiﬁed. Please note that to increase the clarity of the ﬁnal images, cells labelled
with NucGreen Live dye have been marked as yellow using ImageJ.
Nuclear fractionation. Stably expressing p62 cell lines were seeded in 6-well plates
48 h prior to collection. Cells were washed in ice-cold PBS, scrapped in 1 ml
ice-cold PBS and centrifuged for 10 s at 13,000 rpm at 4 °C. The pellet was carefully
resuspended in 1 ml ice-cold 0.1% NP40 in PBS. Overall, 50 μl was collected in a
fresh tube (whole-cell sample). Samples were centrifuged again for 10 s at 13,000
rpm at 4 °C and supernatant, which represents the cytoplasmic fraction, was
discarded. The pellet was resuspended in 1 ml ice-cold 0.1% NP40 in PBS. Samples
were centrifuged for 10 s at 13,000 rpm at 4 °C, supernatant was discarded and the
nuclear pellet and the earlier collected whole-cell lysates were prepared for western
blot analysis. The whole-cell lysate and nuclear pellets were prepared in sample
buffer with β-mE and boiled at 100 °C for 10 min on a thermomixer, shaking at
200 rpm.
ROS measurement. Hydrogen peroxide formation was detected using non-
ﬂuorescent Dihydrorhodamine 123 (DHR, Invitrogen), which after its oxidation by
H2O2 is converted to ﬂuorescent rhodamine. MEFs were seeded in a 12-well plate,
the next day they were treated with PR-619 in the presence or absence of NAC.
Cells were then washed with PBS, followed by trypsinisation. Cells were transferred
to a 15 ml tube, centrifuged for 3 min at 1600 rpm. The pellet was resuspended in
500 μl DMEM containing the DHR dye (5 μM). Following 30 min incubation at 37
°C, cells were centrifuged again for 3 min at 1600 rpm and the pellet was
resuspended in 2 ml DMEM. Cells were immediately analysed by ﬂuorescence-
activated ﬂow cytometry (FACS, Partec). Mean ﬂuorescence values were obtained.
Mouse tissue. Ethical approval for mice was granted by the LERC Newcastle
University, UK; the work was licensed by the UK Home Ofﬁce (PPL 60/3864) and
complied with the guiding principles for the care and use of laboratory animals.
Male, 3 and 24 months old mice of C57Bl6 strain were used in the study. Mice were
housed in same-sex cages in groups of 4 to 6 (56 × 38 × 18 cm, North Kent Plastics,
Kent, UK) and individually identiﬁed by an ear notch. Mice were housed at 20± 2 °
C under a 12 h light/12 h dark photoperiod with lights on at 7.00 am. The diet used
was standard rodent pelleted chow (CRM (P); Special Diets Services, Witham, UK).
Parafﬁn sections were deparafﬁnised with Histo-Clear (National Diagnostics)
and ethanol, antigen was retrieved by incubation in 0.01 M pH 6.0 citrate buffer at
95 °C for 20 min. Slides were incubated in 0.9% H2O2 for 30 min and afterwards
placed in blocking buffer (normal goat serum, Vector Lab) for 30 min at room
temperature. Primary antibody (guinea pig α-p62) was applied overnight at 4 °C.
Slides were washed three times with PBS and incubated for 30 min with secondary
antibody (Vector Lab). Antibodies were detected using peroxidase VECTASTAIN
ABC kit (Vector Lab) according to the manufacturer’s instructions. Substrate
was developed using NovaRED (Vector Lab). Sections were counterstained with
haematoxylin and mounted with DPX (Thermo).
Generation of ‘humanised’ D. melanogaster Ref(2)P. CRISPR/Cas9-Mediated
Genome Editing (homology-dependent repair (HDR) using one guide RNA and a
dsDNA plasmid donor) was utilised to generate a humanised Ref(2)P (CG10360)
(WellGenetics, Taiwan). Amino acids 91–116 of Drosophila (knock-in strain w1118)
Ref(2)P were replaced with amino acids 100–118 of human p62/SQSTM1 peptide.
Guide RNA primers: sense 5′-CTTCGACAGAAGGAGCTTCAGCGT-3′; antisense
5′-AAACACGCTGAAGCTCCTTCTGTC-3′.
Fly husbandry. Flies were crossed and maintained on standard media at 25 °C in a
controlled 12 h light: dark cycle. Male ﬂies were used in all experiments. Survival
graphs were created using Graphpad Prism software and log-rank statistics applied.
Overall, 60 ﬂies were used for each experimental group and three replicate
experiments were performed. Graphs presented depict pooled results.
Paraquat survival. Two day old males (20 ﬂies per vial) were starved overnight on
5 ml 1% agar at 25 °C. Flies were transferred to vials containing ﬁlter paper soaked
in 150 μl of a 5% Sucrose solution with 20 mM Paraquat and maintained at 25 °C.
Dead ﬂies were counted at 12 h intervals and media changed daily.
32 °C survival. 2 day old males (20 ﬂies per vial) were transferred to 32 °C. Media
was changed every 1–2 days and dead ﬂies were counted.
Chloroquine feeding. Two day old males (20 ﬂies per vial) were transferred to
standard media containing 2.5 mg/ml chloroquine. Flies were maintained at 25 °C
for 2 days and then transferred to 32 °C for 2 days. Media was changed every
1–2 days and dead ﬂies were counted.
p62 alignment and in silico calculations. p62 protein sequences in 14 organisms
(Supplementary Table 3) were identiﬁed by searching UniProt for the gene names
SQSTM or Ref(2)P, then removing sequence fragments and choosing the longest
isoform from each organism. Multiple Sequence alignment was carried out using
the Muscle server at EBI (http://www.ebi.ac.uk/Tools/msa/muscle/) with default
parameters. The resulting alignment was visualised using ALINE52. Conservation is
indicated by depth of colour from light-to-dark red, with conservation below 30%
indicated in white. Secondary structure in the PB1 domain was indicated by using
the X-ray crystal structure (PDB entry 4MJS chain B), and in the ZZ zinc-ﬁnger
domain using homology to CBP (PDB entry 1TOT).
Modelling of p62. We carried out modelling of the p62 construct comprising of
PB1 and zinc-ﬁnger domains (residues 3–183). Prediction of an initial 3D structure
of zinc-ﬁnger domain of p62 (residues 121–183) was performed using MOD-
ELLER53 using the crystal structure of human MZM-REP domain of Mib E3
ubiquitin ligase (PDB code: 4XI6) as a template. The sequence identity between the
template and the target was 38%. The model has been reﬁned by molecular-
mechanical energy minimisation (50,000 cycles) and 10 ns of unrestrained all-atom
MD simulation using Gromacs 5.1.254 with Amber99SB-ILDN* force ﬁeld55 and
explicit TIP3P water model. The obtained structure has been ﬁtted on the PB1
domain using protein-protein docking with PatchDock56, and the top ﬁve
predicted models were reﬁned by 50,000 cycles of MM minimisation and 5 ns of
MD simulation. The obtained models were ﬁtted on cryoEM assemblies of p62 PB1
domains (PDB codes 4UF8 and 4UF9), and the ﬁnal model has been selected using
the geometric constraints (relative positions of cysteines, steric clashes overall the
model) and energy-minimised with the disulphide bonds introduced.
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Modelling of the impact of K102E mutation. The mutation has been introduced
to the PB1 domain models (residues 3–125) by manual replacement, followed by
the conformational using UCSF Chimera57. Then, the whole structure of the
mutant (in the monomeric form) has been subjected to 50,000 cycles of MM energy
minimisation, followed by 10 ns of all-atom MD in Gromacs 5.1.2 with TIP3P
explicit water and the Amber99SB-ILDN* force ﬁeld54,55. The wild-type PB1
domains were subjected to the same protocol, as the control group. In the analysis,
we focused on the differences between the interactions in the wild type and the
K102E mutant and on the local sampling of the region surrounding the
mutated residue.
The modelling of the oligomers was done in UCSF Chimera. The positions of
the 102–125 loops were reﬁned using FlexPepDock Monte Carlo approach58. The
ﬁgure has been generated using UCSF Chimera57.
Quantiﬁcation and statistical analysis. Intracellular aggregates of p62 were
scored by eye; the scorer was blinded to the cell treatment and the speciﬁc p62 cell
line. More than 200 cells were counted per slide and quantiﬁcation was based on at
least three independent experiments unless otherwise stated. For autophagosome
(LC3-positive) quantiﬁcation, z-stack images were collected. Using ImageJ software
(NIH), a constant threshold was applied to all the images in the z-stack, and for
every image within each experiment. Cells were scored for % cells with more than
20 autophagosomes per cell. At least 30 cells were quantiﬁed per condition. For
autophagosome quantiﬁcation by EM, the number of autophagosomes per ﬁeld of
view (images taken at ×25k magniﬁcation) was quantiﬁed by eye from 20 images.
Quantiﬁcation of immunoblots was carried out using ImageJ software (NIH).
Two-tailed, unpaired Student’s t-tests were carried out on experimental data from
at least three individual experiments. Fly survival curves were made using
GraphPad Prism and log-rank tests were used for statistical analysis.
Data availability. The authors declare that all the other data supporting the
ﬁndings of this study are available within the article and its supplementary
information ﬁles and from the corresponding author upon request.
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